The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events

Simple item page
dc.contributor.authorMoolman-Smook J.C.
dc.contributor.authorDe Lange W.J.
dc.contributor.authorBruwer E.C.D.
dc.contributor.authorBrink P.A.
dc.contributor.authorCorfield V.A.
dc.date.accessioned2011-05-15T16:15:21Z
dc.date.available2011-05-15T16:15:21Z
dc.date.issued1999
dc.description.abstractHypertrophic cardiomyopathy (HCM) is an autosomal dominantly inherited disease of the cardiac sarcomere, caused by numerous mutations in genes encoding protein components of this structure. Mutation carriers are at risk of sudden cardiac death, mostly as adolescents or young adults. The reproductive disadvantage incurred may explain both the global occurrence of diverse independent HCM-associated mutations and the rare reports of founder effects within populations. We have investigated whether this holds true for two south African subpopulations, one of mixed ancestry and one of northern- European descent. Previously, we had detected three novel mutations - Ala797Thr in the β-myosin heavy-chain gene (βMHC), Arg92Trp in the cardiac troponin T gene (cTnT), and Arg645His in the myosin-binding protein C gene (MyBPC) - and two documented βMHC mutations (Arg403Trp and Arg249Gln). Here we report three additional novel mutations - Gln499Lys in βMHC and Va1896Met and Δc756 in MyBPC - and the documented βMHC Arg719Gln mutation. Seven of the nine HCM-causing mutations arose independently; no conclusions can be drawn for the remaining two. However, the βMHC Arg403Trp and Ala797Thr and cTnT Arg92Trp mutations were detected in another one, eight, and four probands, respectively, and haplotype analysis in families carrying these recurring mutations inferred their origin from three common ancestors. The milder phenotype of the βMHC mutations may account for the presence of these founder effects, whereas population dynamics alone may have overridden the reproductive disadvantage incurred by the more lethal, cTnT Arg92Trp mutation.
dc.description.versionArticle
dc.identifier.citationAmerican Journal of Human Genetics
dc.identifier.citation65
dc.identifier.citation5
dc.identifier.issn00029297
dc.identifier.other10.1086/302623
dc.identifier.urihttp://hdl.handle.net/10019.1/13297
dc.subjectmyosin heavy chain
dc.subjectamino acid substitution
dc.subjectarticle
dc.subjectchromosome 14q
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectfemale
dc.subjectfounder effect
dc.subjectgene mutation
dc.subjectgenetic susceptibility
dc.subjecthuman
dc.subjecthypertrophic cardiomyopathy
dc.subjectmale
dc.subjectpedigree
dc.subjectpriority journal
dc.subjectSouth Africa
dc.subjectCardiomyopathy, Hypertrophic
dc.subjectCarrier Proteins
dc.subjectChromosome Mapping
dc.subjectChromosomes, Human, Pair 14
dc.subjectFemale
dc.subjectFounder Effect
dc.subjectGenotype
dc.subjectHaplotypes
dc.subjectHumans
dc.subjectMale
dc.subjectMutation
dc.subjectMyosin Heavy Chains
dc.subjectPedigree
dc.subjectSouth Africa
dc.subjectTroponin T
dc.titleThe origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events
dc.typeArticle
Files
Collections
Stellenbosch University - Scopus Tygerberg Hospital Publications